U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT06808230) titled 'Cocoa Extract for Migraine Trial' on Jan. 29.
Brief Summary: The goal of this clinical trial is to assess the feasibility of recruitment and adherence to a high-dose cocoa extract supplement in individuals diagnosed with episodic migraine. The main questions it aims to answer are:
* Will we be able to enroll 114 participants during the recruitment period?
* Will participants take study pills daily during the pill-taking period?
Researchers will compare two doses of cocoa extract to placebo to determine the acceptability of higher doses of cocoa extract supplementation in this patient population.
Participants will be asked to:
* ...